Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Canada Postdoctoral Research Award (CPRA) program

McMaster University

$140,000.00

Role of maternal IBD microbiota on immune development and colitis risk in offspring.

EF 2025-26

Résumé
Inflammatory Bowel Disease (IBD) is a lifelong condition of the gut that has no cure and whose exact cause remains unknown. IBD is linked to many genes, but environmental factors, such as the microbes living in the gut and diet, play a central role in driving the inflammation. In Canada, the number of people living with IBD is projected to reach almost 470,000 by 2035. Current treatments reduce inflammation broadly, rather than targeting the underlying drivers, and many patients do not fully respond highlighting the urgent need for new strategies. Recent research suggests that IBD risk may begin before birth. The microbes present in the maternal gut, and the molecules they release, can influence the developing fetus and its immune system. Large clinical studies from Canada show that children born to mothers with active IBD are more likely to develop the disease as they grow up. Supporting this, work from my supervisor's laboratory has shown that people at risk for IBD already have abnormal gut microbial activity before diagnosis. When these microbes were transferred into pregnant germ-free (GF) mice, the offspring developed colitis. This, strongly suggest that maternal microbes play a key role in shaping IBD risk in the next generation. My project will uncover how maternal gut microbes from women with active IBD influence their offspring's immune system. Using a translational approach, I'll colonize pregnant mice with IBD patient microbes and then study the immune cells and microbial molecules in the mothers and their young. Microbial molecules found in both mouse dams and their young will then be tested to see how they affect gut function and immune activation. By discovering how maternal microbes shape immune health across generations, this research will provide new insight into why IBD risk can start before birth. Ultimately, the findings may open the door to new ways of reducing disease risk from the earliest stages of life, offering hope for better prevention.
Programme
Canada Postdoctoral Research Award (CPRA) program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
536747
Name
Mas-Orea Xavier
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Canada Postdoctoral Research Award - A
Projecttitle
Role of maternal IBD microbiota on immune development and colitis risk in offspring.
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Canada Postdoctoral Research Award (CPRA) program
Keyworddelim
Ibd; Immunity; Inflammation; Microbiome; Microbiota; Pregnancy; Unconventional T-Cells
Abstract
Inflammatory Bowel Disease (IBD) is a lifelong condition of the gut that has no cure and whose exact cause remains unknown. IBD is linked to many genes, but environmental factors, such as the microbes living in the gut and diet, play a central role in driving the inflammation. In Canada, the number of people living with IBD is projected to reach almost 470,000 by 2035. Current treatments reduce inflammation broadly, rather than targeting the underlying drivers, and many patients do not fully respond highlighting the urgent need for new strategies. Recent research suggests that IBD risk may begin before birth. The microbes present in the maternal gut, and the molecules they release, can influence the developing fetus and its immune system. Large clinical studies from Canada show that children born to mothers with active IBD are more likely to develop the disease as they grow up. Supporting this, work from my supervisor's laboratory has shown that people at risk for IBD already have abnormal gut microbial activity before diagnosis. When these microbes were transferred into pregnant germ-free (GF) mice, the offspring developed colitis. This, strongly suggest that maternal microbes play a key role in shaping IBD risk in the next generation. My project will uncover how maternal gut microbes from women with active IBD influence their offspring's immune system. Using a translational approach, I'll colonize pregnant mice with IBD patient microbes and then study the immune cells and microbial molecules in the mothers and their young. Microbial molecules found in both mouse dams and their young will then be tested to see how they affect gut function and immune activation. By discovering how maternal microbes shape immune health across generations, this research will provide new insight into why IBD risk can start before birth. Ultimately, the findings may open the door to new ways of reducing disease risk from the earliest stages of life, offering hope for better prevention.
Competitiondate
202509
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Mas-Orea, Xavier
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~